Your browser doesn't support javascript.
loading
Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study.
Friedman, Danielle N; Chou, Joanne F; Clark, Jeanne M; Moskowitz, Chaya S; Ford, Jennifer S; Armstrong, Gregory T; Mubdi, Nidha Z; McDonald, Aaron; Nathan, Paul C; Sklar, Charles A; Ramanathan, Lakshmi V; Robison, Leslie L; Oeffinger, Kevin C; Tonorezos, Emily S.
Afiliación
  • Friedman DN; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chou JF; Weill Cornell Medical College, New York, New York.
  • Clark JM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Moskowitz CS; Johns Hopkins University Schools of Medicine and Public Health, Baltimore, Maryland.
  • Ford JS; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Armstrong GT; Weill Cornell Medical College, New York, New York.
  • Mubdi NZ; Hunter College and The Graduate Center, City University of New York, New York, New York.
  • McDonald A; St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Nathan PC; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sklar CA; St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Ramanathan LV; The Hospital for Sick Children, Toronto, Canada.
  • Robison LL; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Oeffinger KC; Weill Cornell Medical College, New York, New York.
  • Tonorezos ES; Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Epidemiol Biomarkers Prev ; 33(9): 1158-1166, 2024 Sep 03.
Article en En | MEDLINE | ID: mdl-38652494
ABSTRACT

BACKGROUND:

Obesity is prevalent in childhood cancer survivors and interacts with cancer treatments to potentiate risk for cardiovascular (CV) death. We tested a remote weight-loss intervention trial that was effective among adults with CV risk factors in a cohort of adult survivors of childhood acute lymphoblastic leukemia (ALL) with overweight/obesity.

METHODS:

In this phase III efficacy trial, survivors of ALL enrolled in the Childhood Cancer Survivor Study with a body mass index ≥25 kg/m2 were randomized to a remotely delivered weight-loss intervention versus self-directed weight loss, stratified by history of cranial radiotherapy. The primary endpoint was the difference in weight loss at 24 months in an intent-to-treat analysis. Analyses were performed using linear mixed-effects models.

RESULTS:

Among 358 survivors (59% female; median attained age 37 years; IQR 33-43 years), the baseline mean (SD) weight was 98.6 kg (24.0) for the intervention group (n = 181) and 94.9 kg (20.3) for controls (n = 177). Adherence to the intervention was poor; 15% of individuals in the intervention group completed 24/30 planned coaching calls. Weight at 24 months was available for 274 (77%) participants. After controlling for cranial radiotherapy, sex, race/ethnicity, and age, the mean (SE) change in weight from baseline to 24 months was -0.4 kg (0.8) for the intervention group and 0.2 kg (0.6) for control participants (P = 0.59).

CONCLUSIONS:

A remote weight-loss intervention that was successful among adults with CV conditions did not result in significant weight loss among adult survivors of childhood ALL. IMPACT Future interventions in this population must be tailored to the unique needs of survivors to encourage engagement and adherence. See related In the Spotlight, p. 1147.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Supervivientes de Cáncer Límite: Adult / Child / Female / Humans / Male Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Supervivientes de Cáncer Límite: Adult / Child / Female / Humans / Male Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos